Search results
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 6 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 3 days agoThe deal is a negative for Covid vaccine rivals Pfizer and Moderna, Leerink Partners analyst David...
Sarepta’s stock gains after Pfizer’s Duchenne trial failure - Boston Business Journal
The Business Journals· 3 days agoPharma giant Pfizer Inc. (NYSE: PFE) announced on Wednesday after markets closed that its gene...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 6 days ago(Notably, newer versions of omicron have now overtaken XBB.1.5, so the new vaccine's effectiveness...
Another COVID vaccine? Yes, and here’s why
San Jose Mercury News· 5 days agoThis fall, prepare for the latest round of COVID vaccine Whac-a-Mole. Protection against both infection and severe illness is waning. “Effectiveness has...
Pentagon defends anti-vaccine disinformation program in the Philippines
Task & Purpose· 21 hours agoAccording to Reuters’ reporting, the military set up hundreds fake social media accounts, spreading...